These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Reducing the risk of transmitting genital herpes: advances in understanding and therapy. Leone P Curr Med Res Opin; 2005 Oct; 21(10):1577-82. PubMed ID: 16238897 [TBL] [Abstract][Full Text] [Related]
4. A randomised placebo-controlled trial to explore the effect of suppressive therapy with acyclovir on genital shedding of HIV-1 and herpes simplex virus type 2 among Zimbabwean sex workers. Cowan FM; Pascoe SJ; Barlow KL; Langhaug LF; Jaffar S; Hargrove JW; Robinson NJ; Bassett MT; Wilson D; Brown DW; Hayes RJ Sex Transm Infect; 2008 Dec; 84(7):548-53. PubMed ID: 18684855 [TBL] [Abstract][Full Text] [Related]
5. Management of herpes simplex virus type 2 infection in HIV type 1-infected persons. Strick LB; Wald A; Celum C Clin Infect Dis; 2006 Aug; 43(3):347-56. PubMed ID: 16804851 [TBL] [Abstract][Full Text] [Related]
6. Relation between herpes simplex viruses and human immunodeficiency virus infections. Severson JL; Tyring SK Arch Dermatol; 1999 Nov; 135(11):1393-7. PubMed ID: 10566840 [TBL] [Abstract][Full Text] [Related]
7. Once-daily valacyclovir to reduce the risk of transmission of genital herpes. Corey L; Wald A; Patel R; Sacks SL; Tyring SK; Warren T; Douglas JM; Paavonen J; Morrow RA; Beutner KR; Stratchounsky LS; Mertz G; Keene ON; Watson HA; Tait D; Vargas-Cortes M; N Engl J Med; 2004 Jan; 350(1):11-20. PubMed ID: 14702423 [TBL] [Abstract][Full Text] [Related]
8. Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. Celum C; Wald A; Lingappa JR; Magaret AS; Wang RS; Mugo N; Mujugira A; Baeten JM; Mullins JI; Hughes JP; Bukusi EA; Cohen CR; Katabira E; Ronald A; Kiarie J; Farquhar C; Stewart GJ; Makhema J; Essex M; Were E; Fife KH; de Bruyn G; Gray GE; McIntyre JA; Manongi R; Kapiga S; Coetzee D; Allen S; Inambao M; Kayitenkore K; Karita E; Kanweka W; Delany S; Rees H; Vwalika B; Stevens W; Campbell MS; Thomas KK; Coombs RW; Morrow R; Whittington WL; McElrath MJ; Barnes L; Ridzon R; Corey L; N Engl J Med; 2010 Feb; 362(5):427-39. PubMed ID: 20089951 [TBL] [Abstract][Full Text] [Related]
9. Prevention of herpes simplex virus type 2 transmission with antiviral therapy. Corey L; Ashley R; Herpes; 2004 Aug; 11 Suppl 3():170A-174A. PubMed ID: 15319087 [TBL] [Abstract][Full Text] [Related]
10. Risk factors for the sexual transmission of genital herpes. Mertz GJ; Benedetti J; Ashley R; Selke SA; Corey L Ann Intern Med; 1992 Feb; 116(3):197-202. PubMed ID: 1309413 [TBL] [Abstract][Full Text] [Related]
11. Transient Increase in Herpes Simplex Virus Type 2 (HSV-2)-Associated Genital Ulcers Following Initiation of Antiretroviral Therapy in HIV/HSV-2-Coinfected Individuals. Fife KH; Mugwanya K; Thomas KK; Baeten JM; Celum C; Bukusi E; de Bruyn G; Mujugira A; Vwalika B; Wald A; Lingappa JR; J Infect Dis; 2016 May; 213(10):1573-8. PubMed ID: 26704611 [TBL] [Abstract][Full Text] [Related]
12. Current status and prospects for oral acyclovir treatment of first episode and recurrent genital herpes simplex virus. Bryson YJ J Antimicrob Chemother; 1983 Sep; 12 Suppl B():61-5. PubMed ID: 6355052 [TBL] [Abstract][Full Text] [Related]
13. Clinical reactivation of genital herpes simplex virus infection decreases in frequency over time. Benedetti JK; Zeh J; Corey L Ann Intern Med; 1999 Jul; 131(1):14-20. PubMed ID: 10391810 [TBL] [Abstract][Full Text] [Related]
14. Diagnosis and treatment of genital herpes infections. Mertz GJ Infect Dis Clin North Am; 1987 Jun; 1(2):341-66. PubMed ID: 3332794 [TBL] [Abstract][Full Text] [Related]